Dianthus Therapeutics, Inc. (DNTH) Operating cash flow 2016–2025
Dianthus Therapeutics, Inc. (DNTH) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$129.1MFY2025 · since FY2016: -$6.5M → -$129.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$129.1M | -65.1% |
| FY2024 | -$78.2M | -112.1% |
| FY2023 | -$36.9M | -26.8% |
| FY2022 | -$29.1M | +51.2% |
| FY2021 | -$59.5M | +7.0% |
| FY2020 | -$64.0M | -12.1% |
| FY2019 | -$57.1M | -36.3% |
| FY2018 | -$41.9M | -88.1% |
| FY2017 | -$22.3M | -241.0% |
| FY2016 | -$6.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice